Louisiana’s abortion drug access law heightens hemorrhage risk for pregnant patients
Summary
Louisiana passed a law in 2024 that made the drug misoprostol a controlled substance, forcing hospitals to keep it locked away instead of on easy-to-access carts used to treat heavy bleeding after childbirth. Doctors say this delay can increase risks of severe hemorrhages in pregnant patients because the drug is slower to get to those who need it urgently.Key Facts
- Louisiana hospitals previously kept misoprostol on special carts to quickly treat heavy bleeding during pregnancy or after childbirth.
- The 2024 law reclassified misoprostol as a controlled substance, requiring it to be locked in secure rooms.
- Misoprostol is a cheap, safe, and shelf-stable drug used to stop dangerous bleeding.
- The drug is also a key part of medical abortions, which led lawmakers to restrict its access.
- Doctors report that waiting for the drug to be retrieved now causes dangerous treatment delays.
- Some alternative drugs are on the cart but may not be safe for patients with asthma or high blood pressure and are more expensive.
- Misoprostol is also used to prepare for procedures like IUD insertions and to induce labor or manage failed pregnancies.
- The law coincided with a sharp drop in abortion procedures recorded in Louisiana, but many still use medication abortions via telemedicine.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
